Alicia Grande | Chief Financial Officer |
Pat McEnany | Chairman and Chief Executive Officer |
Dan Brennan | Chief Commercial Officer |
Steve Miller | Chief Operating Officer and Chief Scientific Officer |
Gary Ingenito | Chief Medical Officer and Head of Regulatory Affairs |
Charles Duncan | Cantor Fitzgerald |
Joe Catanzaro | Piper Jaffray |
Leland Gershell | Oppenheimer |
Scott Henry | ROTH Capital |
Greetings and welcome to the Catalyst Pharmaceuticals Second Quarter 2019 Results Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded.
It is now my pleasure to introduce your host Ali Grande, Chief Financial Officer.